FEATURED ARTICLES
The Big Idea Behind The Creation Of SIP
Jackie Kent, Lisa Moneymaker, and Jeanette Teague were among the early architects of the Shared Investigator Platform (SIP). In part one of this four-part series, they discuss SIP’s ambitious origins, the challenges of getting competing sponsors to collaborate, and why broad adoption was critical to delivering on its promise of reducing site burden.
-
![navigating the future of healthcare-GettyImages-1785706755]( "Reduce Friction And Save Time: Revamp Site Training To Focus On Value Over Volume")
Reduce Friction And Save Time: Revamp Site Training To Focus On Value Over VolumeTransCelerate BioPharma members Ashlin Dunne, Anne Marie Inglis, and Ann Katrine Miranda assess the state of site training, examine how training affects trial execution, and discuss a better path forward.
-
![woman receiving cancer treatment-GettyImages-1346190289]( "The Promise Of Bispecifics In The Quest For Outpatient Immunotherapy")
The Promise Of Bispecifics In The Quest For Outpatient ImmunotherapySTART San Antonio's Drew Rasco, MD, reflects on the evolution of immunotherapy and highlights how novel therapies such as bispecifics are both challenging and intriguing for principal investigators (PIs).
-
![commercial comparison-GettyImages-912367618]( "The Profit Margin Double Standard That Needs To Change")
The Profit Margin Double Standard That Needs To ChangeWe expect pharmaceutical companies to have sizable profit margins, but we collectively scoff at research sites for achieving the same. Maria P. Ladd explores this difference in expectations and why it needs to change for the sake of the industry.
SERVICES & PRODUCTS
Accelerate trials with a centralized digital workspace that replaces manual documents, boosts collaboration, supports remote access, ensures compliance, and provides real-time visibility.
People-focused, detail-driven (and award-winning!) support for participants, sites, and sponsors.
Scout’s patient concierge team manages payments, travel, and scheduling with precision and empathy—helping sites save time, build trust, and reduce dropouts.
Flexibility matters. Scout helps you plan hybrid and virtual meetings that connect global teams and keep every attendee engaged.
Whether in-person, online, or both, our hybrid meeting solutions for clinical trials make collaboration simple, secure, and human.
With 150+ active sites and partner networks, Altasciences connects your clinical study to optimal locations and patients to reduce risk, accelerate enrollment, and stay on track.
In clinical trials, the patient is the site’s customer — but the site is the CRO’s customer. That’s why we’ve redefined site management and clinical monitoring, merging comprehensive oversight with streamlined efficiency
Clinical trials are how new treatments move from the lab to the people who need them most. By joining a study, you’re not only accessing potential new therapies—you’re helping advance medicine for future generations.